Phrontline Biopharma Employee Directory

Phrontline Biopharma corporate office is located in Suite 502 Building B No. 1976 Middle Gaoke Rd, Pudong New Area, Shanghai, 201210, China and has 11-50 employees.

Employees by Department

Departments

Number of employees

C-Suite

1

Marketing

1

Engineering & Technical

1

Medical & Health

1

Key Employees of Phrontline Biopharma

  • Martin Olivo, Chief Medical Officer at Phrontline Biopharma
    China flag for contact location.
    Martin Olivo

    Chief Medical Officer

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Phrontline Biopharma Global Presence

globalPresence illustration
Asia1-10
North America1-10

Index of contact profiles from Phrontline Biopharma

Hundreds of professionals searching for Phrontline Biopharma have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

People from Similar Companies in the Manufacturing Industry Located in China

Frequently Asked Questions Regarding Phrontline Biopharma Employees

How many employees does Phrontline Biopharma have?
Phrontline Biopharma has 11-50 employees
Who are Phrontline Biopharma key employees?
Some of Phrontline Biopharma key employees are Martin Olivo
Where is Phrontline Biopharma located?
Phrontline Biopharma’s headquarters are located at Suite 502 Building B No. 1976 Middle Gaoke Rd, Pudong New Area, Shanghai, 201210, China
How do I contact Phrontline Biopharma?
Phrontline Biopharma Contact Info: Phone number: +86 2150476277 Website: www.phrontlinebio.com
What does Phrontline Biopharma do?

Phrontline Biopharma is a clinical-stage biotechnology company headquartered in Suzhou, China, dedicated to developing innovative antibody-drug conjugates to address unmet medical needs in oncology. The company specializes in engineering bispecific dual-payload ADCs, utilizing proprietary technology platforms to enhance the precision and efficiency... of therapeutic delivery. Phrontline Biopharma focuses on optimizing dual targeting to increase patient coverage and improve tumor cell internalization, while employing dual payloads to overcome drug resistance, tumor heterogeneity, and enhance durability of response. The company's approach aims to address the limitations of traditional single-payload, single-target ADCs by delivering two different mechanisms of action payloads to cancer cells simultaneously. Phrontline Biopharma operates through integrated technology platforms including its SynTume and 2by2 ADC systems, advancing multiple preclinical and clinical programs targeting various solid tumors. The company has established strategic partnerships with major pharmaceutical companies to co-develop investigational ADC assets directed against targets expressed in a broad range of cancers, including EGFR and HER3. Founded in 2022, Phrontline Biopharma is committed to advancing more effective and durable treatment options for patients with high unmet medical needs through in-house innovation.Read More

Is Phrontline Biopharma a public company?
Phrontline Biopharma is private company therefore does not currently have an official ticker symbol
See more information about Phrontline Biopharma Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.